Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Cuernavaca
Clinical trial register · Mexico

Clinical Trials in Cuernavaca, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Mexico and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1585 matching records held by the registry are in this view. Synced 09 Oct 2026, 03:18 UTC
1585
Studies in scope
all four open statuses
715
Recruiting now
open to new participants
254
Lead sponsors
across recruiting studies
Top sites
Guadalajara 40 Mexico City 33 Chihuahua City 32 Monterrey 28 Mérida 14
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Eli Lilly and Company12 AstraZeneca7 Boehringer Ingelheim4 Merck Sharp & Dohme LLC3 Hoffmann-La Roche3 Clear sponsor filter
Site location
Guadalajara40 Mexico City33 Chihuahua City32 Monterrey28 Mérida14
All 46 locations
Target enrolment
to

Trials with a site in Cuernavaca

12 of 1585 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Mexico
Start
Recruiting
Eli Lilly and Company
Phase 3
1,000
Chihuahua City, Ciudad de Tijuana, Cuernavaca, Culiacán, Mexico City, Mérida, Veracruz, Zapopan
2026-08-14
Recruiting
Eli Lilly and Company
Phase 2
531
Ciudad de Tijuana, Cuernavaca, Guadalajara, Irapuato, Mexico City, Mérida, Tlalnepantla, Torreón
2026-05-06
Recruiting
Eli Lilly and Company
Phase 3
7,140
Actopan, Ciudad Madero, Cuernavaca, Culiacán, Durango, Guadalajara, Hermosillo, León
2025-12-01
Recruiting
Eli Lilly and Company
Phase 3
4,500
Chihuahua City, Cuauhtémoc, Cuernavaca, Guadalajara, Metepec, Mexico City, Mérida, Monterrey
2025-10-15
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Actopan, Aguascalientes, Ciudad Madero, Cuernavaca, Culiacán, Guadalajara, Hermosillo, León
2025-09-02
Active, closed
Eli Lilly and Company
Phase 3
10,000
Actopan, Aguascalientes, Ciudad Madero, Cuauhtémoc, Ciudad de México, Cuernavaca, Durango, Guadalajara, León
2024-04-30
Active, closed
Eli Lilly and Company
Phase 3
17,300
Aguascalientes, Chihuahua City, Cuernavaca, Culiacán, Durango, Guadalajara, Hermosillo, León
2024-03-05
Active, closed
Eli Lilly and Company
Phase 3
1,250
Guadalajara, Mexico City, Cuernavaca, Monterrey, Chihuahua City, Veracruz
2024-02-21
By invitation
Eli Lilly and Company
Phase 3
333
Chihuahua City, Zapopan, Mexico City, Cuernavaca, Monterrey, Veracruz
2023-03-09
Active, closed
Eli Lilly and Company
Phase 3
377
Chihuahua City, Cuernavaca, Mexico City, Monterrey, Veracruz, Zapopan
2022-10-18
Active, closed
Eli Lilly and Company
Phase 3
15,374
Aguascalientes, Chihuahua City, Ciudad Madero, Cuauhtémoc, Cuernavaca, Culiacán, Durango, Guadalajara
2022-10-11
Active, closed
Eli Lilly and Company
Phase 3
493
Torreón, México, León, Guadalajara, Mexico City, Cuernavaca, Juchitán de Zaragoza, Colinas Del Cimatario
2014-11-06
Rows per page Showing 1–12 of 12
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Mexican investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-mexico/city/cuernavaca

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Mexico and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,585 studies in total at the last sync on 09 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 12 of those studies with a site in Cuernavaca that also match the filters currently applied.

How many clinical trials are recruiting in Cuernavaca?

5 of the 12 studies on this page are recruiting new participants as of the 09 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 6 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Cuernavaca), 12 studies
PhaseStudiesRecruitingShare
Phase 311491.7%
Phase 2118.3%

Most active sponsors

Lead sponsors with the most studies (Cuernavaca)
Lead sponsorStudiesRecruiting
Eli Lilly and Company125
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.